Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

GLG News by Users of Mass Spectrometers in the U.S.

Gregory Khitrov, Director of Personalized Medicine Program

Gregory KhitrovDirector of Personalized Medicine ProgramMOUNT SINAI SCHOOL OF MEDICINE OF What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

the way to go, the alternative fuil future is now

March 19, 2009

Toyota to develop affordable hybrid vehicle | www.marketwatch.com

Starting to work on slowing down our dependence on foreign oil

Joseph SchappertMedical Director PROVIDENCE HEALTH CARE What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Surgical Pathology 'Goldrush'

February 13, 2009

Dako announces a collaboration with OSI Pharmaceuticals, Inc. on Companion Diagnostics | www.tmcnet.com

The ability of pharma and biotech to leverage the rapid expansion in our knowledge base on cell surface, nuclear and cytoplasmic signaling and messaging systems has and will continue to produce novel targeted molecules. To identify which patients will respond and potential surrogate markers for the assessment of a molecule's success will require reagents that are applied to histologic sections. These capabilities, combined with imaging and data reduction of the stained sections, should be anticipated to provide a very lucrative market for companies in this diagnostic arena and to facilitate the timely introduction of effective novel markers.

Mark Tapsak, Assistant Professor

Mark TapsakAssistant ProfessorBLOOMSBURG UNIVERSITY OF PENNSYLVANIA What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Industry leaders need to work with the US Patent and Trademark office to keep US patents strong

April 24, 2008

Federal Court Sides With GlaxoSmithKline, Strikes Down Rules Issued by Patent Office | biz.yahoo.com

The USPTO is facing an epidemic amount of frivolous patents.  This degrades their ability to review strong and potentially important patents in a timely manner.  Although this particular change was struck down in Federal court, industry leaders need to work with the USPTO in order to strengthen the US patent system.   

Mark Tapsak, Assistant Professor

Mark TapsakAssistant ProfessorBLOOMSBURG UNIVERSITY OF PENNSYLVANIA What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

CooperVision enters US market with Avaira™ two-week silicone hydrogel contact lenses

April 16, 2008

CooperVision Introduces Avaira™ Two-Week Silicone Hydrogel Contact Lenses | www.coopervision.com

I’m not so sure that this is a leap forward for CooperVision.  After long delays for the release of the Biofinity lens, a two-week version has just been released.  The material properties are reportedly “nice”, but certainly scaled back from what was reportedly achieved with Comfilcon A.      

Joseph SchappertMedical Director PROVIDENCE HEALTH CARE What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Novel molecules and diagnostic tests

February 19, 2008

Kidney Cancer Drug Linked to Higher Rate of Heart Problems | www.washingtonpost.com

Diagnostic tools are availible to identify these adverse effects at an early stage in their clinical development. These tools should mitigate the seriousness of these adverse events.

Mark Tapsak, Assistant Professor

Mark TapsakAssistant ProfessorBLOOMSBURG UNIVERSITY OF PENNSYLVANIA What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

DexCom Makes Progress Towards Easier Glucose Monitoring

November 19, 2007

Dexcom says gets FDA OK to calibrate glucose monitoring system | www.reuters.com

It's not easy being small, especially in the world of medical devices. Big players leverage branding, large sales forces and deep R&D organizations when they bring technologies to market. Unfortunately, most products are incremental improvements at best. Rarely does the conservative healthcare market benefit from a “leapfrog event”. DexCom announced today that the FDA approved a new calibration process for its seven day glucose sensor. While this announcement may appear trivial, it demonstrates steady progress for an important medical device by a relatively small company.  

Mark Tapsak, Assistant Professor

Mark TapsakAssistant ProfessorBLOOMSBURG UNIVERSITY OF PENNSYLVANIA What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

All plastics are not created equal, choose wisely young biomedical engineer

October 22, 2007

Materials: Adding Sustainability to Product Development | www.devicelink.com

Material choices for the designer of medical devices are traditionally limited to those that already enjoy a proven track record. The use of truly new materials in a medical device is not only risky for the device manufacturer, but also for the material manufacturer. In particular, tissue contacting devices pose substantial litigation risks for material suppliers.

Mark Tapsak, Assistant Professor

Mark TapsakAssistant ProfessorBLOOMSBURG UNIVERSITY OF PENNSYLVANIA What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Delayed availability for Comfilcon A silicone hydrogel lenses from CooperVision

October 19, 2007

Comfilcon A: A New Silicone Hydrogel Material | www.clspectrum.com

Silicone hydrogel materials will continue to push the boundaries of high oxygen transmissibility (Dk/t) and low modulus contact lenses. From a research and development standpoint, the fundamental starting materials have been under development for decades. CooperVision’s competitors in this arena have invested significantly more R&D resources to these projects for a number of years. Although the article by Dr. Lyndon Jones compares the material performance of Biofinity lenses to competing products, these desirable properties may never be achieved without a stronger R&D effort by CooperVision.  

Joseph SchappertMedical Director PROVIDENCE HEALTH CARE What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Microrganisms elude our control

March 5, 2007

Proof Nailed Down that Antibiotics Use Leads to Resistance | www.medpagetoday.com

Our experience with antibiotics has consistently shown that resistance occurs within 3-5 years of their widespread utilization. Our more recent experience with antiviral agents has been similar. Without diminishing the important role that antimicrobials have played in our recent history, it has also underscored their limitations. While this is of concern, there is also considerable concern in the international microbiology community regarding mutations within microorganisms that would allow them to 'jump species' and infect humans, or would enhance the virulence of existing pathogens. This fear is enhanced by the indiscriminate utilization of antimicrobial agents associated with ‘modern’ agricultural practices worldwide, which are changing the microbial ecology and potentially selecting out new pathogens to humans and/or to our food supply.

 

Joseph SchappertMedical Director PROVIDENCE HEALTH CARE What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

The future of clinical laboratory diagnostics

March 5, 2007

GE to acquire Abbott's invitro and point of care diagnostics businesses | egems.gehealthcare.com

The purchase of Abbott Diagnostics (ADD) by General Electric follows the purchase of Bayer Diagnostics and DPC by Siemens. It can be anticipated that GE will purchase a second diagnostics company. Since this is part of a restructuring of the diagnostics industry away from pharmaceutical companies to electronics companies, it should also be anticipated that Philips and possibly IBM would enter this arena in the very near future

Page : 11 to 10 of 10

Leading institutions connect with members of the Healthcare councils through GLG

Most Popular Healthcare News